Regeneron Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Regeneron Pharmaceuticals patents 453 in total
| Status | Patent |
|---|---|
Application | Utility: Genome-Based Methods For Reducing Cardiovascular Risk Filling date: 13 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-33 ANTAGONIST Filling date: 13 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: MODELING TDP-43 PROTEINOPATHY Filling date: 13 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: METHOD OF DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS Filling date: 13 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: B4GALT1 Variants And Uses Thereof Filling date: 13 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND PSMA AND CD3 IN COMBINATION WITH 4-1BB CO-STIMULATION Filling date: 13 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3 IN COMBINATION WITH 4-1BB CO-STIMULATION Filling date: 13 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING PAIN IN SUBJECTS WITH RHEUMATOID ARTHRITIS Filling date: 13 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR THERAPEUTIC PROTEIN DELIVERY Filling date: 13 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: ANTI-PCRV ANTIBODIES THAT BIND PCRV, COMPOSITIONS COMPRISING ANTI-PCRV ANTIBODIES, AND METHODS OF USE THEREOF Filling date: 13 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: METHODS FOR IDENTIFYING AND QUANTITATING HOST CELL PROTEIN Filling date: 13 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: ANGPTL8 ASSAY AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: NON-HUMAN ANIMALS COMPRISING A HUMANIZED ALBUMIN LOCUS Filling date: 13 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: NON-HUMAN ANIMALS COMPRISING A HUMANIZED TTR LOCUS WITH A BETA-SLIP MUTATION AND METHODS OF USE Filling date: 13 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: Maytansinoid Derivatives, Conjugates Thereof, and Methods of Use Filling date: 13 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: VL ANTIGEN BINDING PROTEINS EXHIBITING DISTINCT BINDING CHARACTERISTICS Filling date: 13 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind STEAP2 and CD3, and Uses Thereof Filling date: 13 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE Filling date: 13 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX ANIMALS Filling date: 13 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: HUMAN ANTIBODIES TO INFLUENZA HEMAGGLUTININ Filling date: 13 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR Filling date: 13 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: METHOD FOR GENERATING HIGH AFFINITY ANTIBODIES Filling date: 13 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: NON-HUMAN ANIMALS HAVING A HEXANUCLEOTIDE REPEAT EXPANSION IN A C9ORF72 LOCUS Filling date: 13 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: CHARACTERIZATION OF DOMAIN-SPECIFIC CHARGE VARIANTS OF ANTIBODIES Filling date: 13 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: Synaptojanin 2 (SYNJ2) Variants And Uses Thereof Filling date: 13 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: STABILIZED FORMULATIONS CONTAINING ANTI-ANGPTL3 ANTIBODIES Filling date: 13 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: RIFAMYCIN ANALOGS AND ANTIBODY-DRUG CONJUGATES THEREOF Filling date: 13 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: Competitive Ligand Binding Assays Filling date: 13 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: HSD17B13 VARIANTS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: ROTATABLE SURGICAL TABLE Filling date: 13 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING Filling date: 13 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: COMBINATION OF IL-4/IL-13 PATHWAY INHIBITORS AND PLASMA CELL ABLATION FOR TREATING ALLERGY Filling date: 13 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: METHOD OF TREATING OSTEOARTHRITIS WITH AN ANTIBODY TO NGF Filling date: 13 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING JUVENILE IDIOPATHIC ARTHRITIS Filling date: 13 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: HUMAN ANTIBODIES TO PD-1 Filling date: 13 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: METHODS FOR TREATING EOSINOPHILIC ESOPHAGITIS BY ADMINISTERING AN IL-4R INHIBITOR Filling date: 13 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: IDENTIFICATION OF HOST CELL PROTEINS Filling date: 13 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: Isolating Cells Expressing Secreted Proteins Filling date: 13 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof Filling date: 13 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR INSERTION OF ANTIBODY CODING SEQUENCES INTO A SAFE HARBOR LOCUS Filling date: 13 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: METHODS FOR SCARLESS INTRODUCTION OF TARGETED MODIFICATIONS INTO TARGETING VECTORS Filling date: 13 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: NON-HUMAN ANIMALS COMPRISING A HUMANIZED COAGULATION FACTOR 12 LOCUS Filling date: 13 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: System and Method for Characterizing Protein Dimerization Filling date: 13 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: DEVICES AND METHODS FOR PRECISION DOSE DELIVERY Filling date: 13 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: METHODS FOR ANALYSIS OF VIRAL CAPSID PROTEIN COMPOSITION Filling date: 13 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING AN IL-4R INHIBITOR Filling date: 13 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: EGFR x CD28 MULTISPECIFIC ANTIBODIES Filling date: 13 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: Stabilized Formulations Containing Anti-IL-33 Antibodies Filling date: 13 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Protein Cleavage-Activating Protein (SCAP) Inhibitors Filling date: 13 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1) Inhibitors Filling date: 13 Sep 2025 Issue date: 24 Sep 2020 |
Showing 200 to 250 of 453 patents.